China Resources Sanjiu Medical & Pharmaceutical Co Ltd Capital Reinvestment Ratio
China Resources Sanjiu Medical & Pharmaceutical Co Ltd capital reinvestment ratio. China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Capital Reinvestment Ratio of 0.21x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥2.60 Billion) in capital expenditures (CN¥545.33 Million). See free cash flow generation of China Resources Sanjiu Medical & Pharmac to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2025)
Capital reinvestment ratio of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1999 to 2025. This chart tracks China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 26 annual periods. See financial flexibility index of China Resources Sanjiu Medical & Pharmac to measure the company's free cash flow as a share of total liabilities.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (1999–2025)
China Resources Sanjiu Medical & Pharmaceutical Co Ltd capital reinvestment ratio by year from 1999 to 2025. For the full cash flow conversion analysis, see cash flow conversion of China Resources Sanjiu Medical & Pharmac.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | CN¥5.51 Billion | CN¥1.27 Billion | ▲ +28.5% |
| 2024 | 0.18x | CN¥4.40 Billion | CN¥790.07 Million | ▼ -12.2% |
| 2023 | 0.20x | CN¥4.19 Billion | CN¥857.21 Million | ▼ -35.4% |
| 2022 | 0.32x | CN¥3.01 Billion | CN¥951.57 Million | ▼ -31.5% |
| 2021 | 0.46x | CN¥1.88 Billion | CN¥870.80 Million | ▲ +65.3% |
| 2020 | 0.28x | CN¥2.22 Billion | CN¥621.82 Million | ▲ +2.9% |
| 2019 | 0.27x | CN¥1.97 Billion | CN¥535.97 Million | ▼ -13.5% |
| 2018 | 0.31x | CN¥1.91 Billion | CN¥600.36 Million | ▲ +34.0% |
| 2017 | 0.23x | CN¥1.60 Billion | CN¥374.74 Million | ▼ -7.9% |
| 2016 | 0.25x | CN¥1.39 Billion | CN¥354.33 Million | ▼ -3.0% |
| 2015 | 0.26x | CN¥1.26 Billion | CN¥330.65 Million | ▼ -8.9% |
| 2014 | 0.29x | CN¥1.18 Billion | CN¥341.22 Million | ▲ +19.1% |
| 2013 | 0.24x | CN¥1.47 Billion | CN¥354.89 Million | ▼ -41.9% |
| 2012 | 0.42x | CN¥1.21 Billion | CN¥504.52 Million | ▼ -3.0% |
| 2011 | 0.43x | CN¥954.90 Million | CN¥409.79 Million | ▲ +34.8% |
| 2010 | 0.32x | CN¥848.28 Million | CN¥270.00 Million | ▲ +41.1% |
| 2009 | 0.23x | CN¥855.05 Million | CN¥192.93 Million | ▼ -79.1% |
| 2008 | 1.08x | CN¥1.12 Billion | CN¥1.20 Billion | ▲ +187.7% |
| 2007 | 0.37x | CN¥605.30 Million | CN¥226.78 Million | ▲ +17.4% |
| 2006 | 0.32x | CN¥425.51 Million | CN¥135.81 Million | ▼ -80.4% |
| 2005 | 1.63x | CN¥22.83 Million | CN¥37.14 Million | ▼ -66.4% |
| 2003 | 4.84x | CN¥28.09 Million | CN¥135.88 Million | ▲ +1289.6% |
| 2002 | 0.35x | CN¥496.12 Million | CN¥172.67 Million | ▼ -55.1% |
| 2001 | 0.77x | CN¥153.44 Million | CN¥118.83 Million | ▲ +21.2% |
| 2000 | 0.64x | CN¥266.86 Million | CN¥170.58 Million | ▲ +5.0% |
| 1999 | 0.61x | CN¥120.63 Million | CN¥73.43 Million | — |